AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Overview Fund Activity
Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

76 hedge funds and large institutions have $101M invested in AVEO Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 9 closing their positions.

Holders
76
Holders Change
+11
Holders Change %
+16.92%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
21
Reduced
19
Closed
9
Calls
$7.28M
Puts
$5.28M
Net Calls
+$2M
Net Calls Change
+$2.03M

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$11M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$7.06M
3
OM
3
Opaleye Management
Massachusetts
$6.11M
4
CCP
4
Clough Capital Partners
Massachusetts
$2.2M
5
MIM
5
Monashee Investment Management
Massachusetts
$1.83M

Top Sellers

1
SAM
1
Sectoral Asset Management
Quebec, Canada
$185K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$60K
3
Squarepoint
3
Squarepoint
New York
$174K
4
Millennium Management
4
Millennium Management
New York
$85K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$137K
Name Holding Trade Value Shares
Change 		Shares
Change %
WA
76
WealthTrust Axiom
Pennsylvania
– -$128K -22,347 Closed
HSBC Holdings
77
HSBC Holdings
United Kingdom
– -$125K -21,897 Closed
WG
78
Winton Group
United Kingdom
– -$111K -19,235 Closed
CH
79
CVI Holdings
Delaware
– -$76K -13,171 Closed
KAS
80
Kestra Advisory Services
Texas
– -$70K -12,200 Closed
SSA
81
Schonfeld Strategic Advisors
New York
– -$65K -11,200 Closed
TWM
82
Tradition Wealth Management
Minnesota
– -$1K -233 Closed
1 2 3
4